share_log

荣昌生物(09995.HK)遭易方达基金减持53.6万股

Remegen (09995.HK) had 536,000 shares of shareholding reduced by E Fund.

Gelonghui Finance ·  Jun 24 07:36

According to the latest equity disclosure information from HKEX on June 24th, 2024, on June 18th, 2024, Remegen (09995.HK) was reduced by E Fund Management Co., Ltd. to 536,000 shares at an average price of HKD 26.5858 per share, involving approximately HKD 14.25 million.

After the shareholding reduction, the latest number of shares held by E Fund Management Co., Ltd. is 9.1615 million shares, and the shareholding ratio has decreased from 5.12% to 4.83%.

big

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment